Loading...

Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes

OBJECTIVE: Rebamipide ophthalmic suspension was developed for the treatment of dry eyes and for other corneal diseases, promoting the secretion of both mucin in tear fluid and membrane-associated mucin, increasing the number of goblet cells, and restoring the barrier function of the corneal epitheli...

Full description

Saved in:
Bibliographic Details
Published in:Int Med Case Rep J
Main Authors: Hayashi, Yusuke, Toshida, Hiroshi, Matsuzaki, Yusuke, Matsui, Asaki, Ohta, Toshihiko
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2016
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872273/
https://ncbi.nlm.nih.gov/pubmed/27257394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S103299
Tags: Add Tag
No Tags, Be the first to tag this record!